Drug Profile
Research programme: adenosine A1 receptor allosteric enhancers - PGxHealth
Latest Information Update: 20 Aug 2009
Price :
$50
*
At a glance
- Originator Adenosine Therapeutics LLC
- Class
- Mechanism of Action Adenosine A1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy; Pain
Most Recent Events
- 20 Aug 2009 Discontinued - Preclinical for Epilepsy in USA (unspecified route)
- 20 Aug 2009 Discontinued - Preclinical for Pain in USA (unspecified route)
- 25 Aug 2006 Preclinical trials in Epilepsy in USA (unspecified route)